{
    "organizations": [],
    "uuid": "d9f8a7eb6e51b7fd921838196a7b69fa1ab49a18",
    "author": "",
    "url": "https://www.reuters.com/article/brief-corbus-pharmaceuticals-reports-q1/brief-corbus-pharmaceuticals-reports-q1-loss-per-share-0-21-idUSASC0A1EY",
    "ord_in_thread": 0,
    "title": "BRIEF-Corbus Pharmaceuticals Reports Q1 Loss Per Share $0.21",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10, 2018 / 12:14 PM / Updated 11 minutes ago BRIEF-Corbus Pharmaceuticals Reports Q1 Loss Per Share $0.21 Reuters Staff\nMay 10 (Reuters) - Corbus Pharmaceuticals Holdings Inc :\n* CORBUS PHARMACEUTICALS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE * CORBUS PHARMACEUTICALS HOLDINGS INC Q1 SHR LOSS $0.21\n* CORBUS PHARMACEUTICALS HOLDINGS INC Q1 SHR VIEW $-0.14 â€” THOMSON REUTERS I/B/E/S\n* CORBUS PHARMACEUTICALS HOLDINGS INC - EXPECTS TO REPORT TOPLINE RESULTS FOR PHASE 2B CF STUDY IN FIRST HALF OF 2020.\n* CORBUS PHARMACEUTICALS - EXPECTS CURRENT CASH AND CASH EQUIVALENTS WITH OTHER PAYMENTS TO FUND OPERATIONS THROUGH Q4 2019\n* CORBUS PHARMACEUTICALS HOLDINGS INC - ENDED Q1 WITH APPROXIMATELY $71.0 MLN OF CASH AND CASH EQUIVALENTS\n* CORBUS PHARMACEUTICALS HOLDINGS INC - REVENUE FOR QUARTER DECREASED BY APPROXIMATELY $0.3 MLN TO $1.0 MLN FROM QUARTER ENDED MARCH 31, 2017 Source text for Eikon: ",
    "published": "2018-05-10T15:13:00.000+03:00",
    "crawled": "2018-05-10T15:28:28.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "report",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "corbus",
        "pharmaceutical",
        "holding",
        "inc",
        "corbus",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "corbus",
        "pharmaceutical",
        "holding",
        "inc",
        "q1",
        "shr",
        "loss",
        "corbus",
        "pharmaceutical",
        "holding",
        "inc",
        "q1",
        "shr",
        "view",
        "thomson",
        "reuters",
        "corbus",
        "pharmaceutical",
        "holding",
        "inc",
        "expects",
        "report",
        "topline",
        "result",
        "phase",
        "2b",
        "cf",
        "study",
        "first",
        "half",
        "corbus",
        "pharmaceutical",
        "expects",
        "current",
        "cash",
        "cash",
        "equivalent",
        "payment",
        "fund",
        "operation",
        "q4",
        "corbus",
        "pharmaceutical",
        "holding",
        "inc",
        "ended",
        "q1",
        "approximately",
        "mln",
        "cash",
        "cash",
        "equivalent",
        "corbus",
        "pharmaceutical",
        "holding",
        "inc",
        "revenue",
        "quarter",
        "decreased",
        "approximately",
        "mln",
        "mln",
        "quarter",
        "ended",
        "march",
        "source",
        "text",
        "eikon"
    ]
}